Literature DB >> 1972819

Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours.

J Hustin1, Y Gillerot, J Collette, P Franchimont.   

Abstract

The evolution of the gonads during intra-uterine development has been followed by immunohistochemical demonstration of placental-like alkaline phosphatase (PLAP) at the germ-cell level. PLAP immunopositivity was restricted to the limited period when germ cells were not surrounded by granulosa or Sertoli cells. Abnormal fetuses or neonates presenting with chromosomal anomalies frequently had disorganized gonads where germ cells retained their membrane PLAP immunopositivity. This abnormal immunopositivity is similar to that expressed by abnormal germ cells in testicular in situ carcinoma, in gonadoblastoma (case of 45,XO/46,XY mosaic) and in seminoma. The pattern of positivity for other germ-cell tumours was highly variable. We suggest that in abnormal gonads, dysgenetic or neoplastic, an early embryonic property is retained by abnormal germ cells. Its importance in the process of neoplastic induction remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972819     DOI: 10.1007/bf01600111

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  15 in total

1.  Histochemical observations on the germ cells of human embryos.

Authors:  D G McKAY; A T HERTIG; E C ADAMS; S DANZIGER
Journal:  Anat Rec       Date:  1953-10

Review 2.  Antigen expression by human trophoblast and tumour cells: models for gene regulation?

Authors:  J M Risk; P M Johnson
Journal:  Contrib Gynecol Obstet       Date:  1985

3.  The pathology of trisomy 13 syndrome. A study of 12 cases.

Authors:  P Moerman; J P Fryns; K van der Steen; A Kleczkowska; J Lauweryns
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

4.  Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast-associated determinants.

Authors:  P Travers; W Bodmer
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

5.  A deletion map of the human Y chromosome based on DNA hybridization.

Authors:  G Vergnaud; D C Page; M C Simmler; L Brown; F Rouyer; B Noel; D Botstein; A de la Chapelle; J Weissenbach
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

6.  Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis.

Authors:  J Müller; N E Skakkebaek; M Ritzén; L Plöen; K E Petersen
Journal:  J Pediatr       Date:  1985-03       Impact factor: 4.406

7.  Placental alkaline phosphatase as a tumor marker for seminoma.

Authors:  P H Lange; J L Millan; T Stigbrand; R L Vessella; E Ruoslahti; W H Fishman
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

8.  Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.

Authors:  J O Davies; E R Davies; K Howe; P Jackson; E Pitcher; B Randle; C Sadowski; G M Stirrat; C A Sunderland
Journal:  J R Soc Med       Date:  1985-11       Impact factor: 5.344

9.  Immunohistochemical localization of placental-like alkaline phosphatase in testis and germ-cell tumors using monoclonal antibodies.

Authors:  J Paiva; I Damjanov; P H Lange; H Harris
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

10.  Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours.

Authors:  J Hustin; J Collette; P Franchimont
Journal:  Int J Androl       Date:  1987-02
View more
  2 in total

Review 1.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

Review 2.  Alkaline phosphatase in stem cells.

Authors:  Kateřina Štefková; Jiřina Procházková; Jiří Pacherník
Journal:  Stem Cells Int       Date:  2015-02-12       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.